📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 21:01
232 analysed today
FollowTelegram
232
Today
149,633
All-time analysed
42,906
Positive
6,661
Negative
91,389
Neutral
8,609
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
38 announcements match the current filters (relevance ≥ 5).
Blue Star arm to sell MedTech division for up to ₹40 Cr via slump sale
Blue Star Limited's wholly owned subsidiary, Blue Star Engineering & Electronics Limited, has executed a Business Transfer Agreement to sell its MedTech division to Cyrix Healthcare for up to ₹40 crore. The division contributed ₹42.13 crore in revenue (0.33% of consolidated revenue) and ₹7.11 crore in net worth (0.21% of consolidated net worth) during FY26. The transaction is being undertaken to sharpen focus on core strategic priorities and is expected to complete by March 31, 2027.
Confidence: HIGH
What changedBlue Star's subsidiary executed an agreement to divest its medical diagnostic equipment and services (MedTech) business to Cyrix Healthcare.
Why it mattersThe disposal sheds a non-core, sub-1% revenue unit at an exit valuation above book value, allowing the group to concentrate resources on HVAC, commercial refrigeration, and exports.
Deal consideration: Upto ₹40 croreFY26 division revenue: ₹42.13 croreDivision revenue share: 0.33%Division net worth: ₹7.11 croreTarget completion date: March 31, 2027
📅 Short termMinimal financial and market impact in the short term given the division's negligible contribution to Blue Star's ₹12,520 Cr TTM top-line.
📈 Long termSupports strategic focus by exiting a non-core segment and reallocating management bandwidth toward core consumer and commercial cooling opportunities.
⚠ Risk flags
- Fulfillment of conditions precedent prior to March 31, 2027 closing
Key Highlights
Slump sale consideration of up to ₹40 crore from Cyrix Healthcare Private Limited
MedTech division FY26 turnover was ₹42.13 crore (~0.33% of consolidated income)
Divisional net worth was ₹7.11 crore (~0.21% of consolidated net worth) as of March 31, 2026
Target completion date for the slump sale is March 31, 2027, subject to closing conditions
👀 What to Watch
Track fulfillment of conditions precedent ahead of the March 31, 2027 completion deadline and monitor redeployment of capital into core cooling segments.
Blue Star Q1 FY27: Segment II Margins Drop to 2.9% Amid Pricing Pressure; Order Book at Rs 7,764 Cr
Blue Star reported a challenging Q1 FY27 where Segment II (Room AC) EBIT margins contracted sharply to 2.9% from 5.8% YoY, primarily due to an inability to pass on 13% in input cost hikes. While overall revenue grew 13%, the company faced headwinds from a late summer and high trade inventory, resulting in only 5% of costs being passed to consumers. Conversely, the B2B segment remains robust with a record carried-forward order book of Rs 7,764 Cr, including Rs 1,500 Cr in new data center MEP orders. Management expects a recovery in the second half, targeting a full-year Segment II operating margin of 6.5%.
Confidence: HIGH
What changedSignificant margin contraction in the Room AC segment due to competitive pricing and unabsorbed commodity costs, despite steady revenue growth.
Why it mattersThe results highlight intense competition in the consumer AC market, making the company increasingly dependent on its high-growth B2B data center cooling segment to sustain overall profitability.
Segment II EBIT Margin: 2.9%Carried Forward Order Book: Rs 7,764 CrOrder Book vs TTM Revenue: 64.04%Data Center Order Inflow (Q1): Rs 1,500 CrNet Cash Position: Rs 900 CrUnrecovered Cost Hike: 8%
📅 Short termThe stock may face pressure due to the margin disappointment in the core consumer segment, with recovery contingent on festive season demand.
📈 Long termStructural growth in data center cooling and a strong B2B order book provide a long-term hedge against the volatile and competitive consumer AC market.
⚠ Risk flags
- Intense pricing competition in RAC segment
- Commodity price and exchange rate volatility
- BEE rating change-led inventory liquidation risks
Key Highlights
Segment II EBIT margins fell 300 basis points YoY to 2.9% in Q1 FY27.
Total carried forward order book reached a record Rs 7,764 Cr, representing ~64% of TTM revenue.
Management failed to pass on 8% of the targeted 13% input cost increase to consumers during the quarter.
Data center MEP projects contributed Rs 1,500 Cr in order inflows, with a target of Rs 4,000 Cr revenue by FY29.
Net cash position improved significantly to Rs 900 Cr from Rs 371 Cr in the previous year.
👀 What to Watch
Monitor the company's ability to 'rejig' its product portfolio and implement price hikes during the Q3 festive season. Watch for potential pricing pressure in December 2026 due to the BEE energy rating change and inventory liquidation.
Blue Star Q1 FY27: Revenue up 13% to ₹3,378 Cr, but PBT drops 24% on margin pressure
Blue Star reported a 13.3% YoY revenue growth to ₹3,378 Cr for Q1 FY27, supported by strong demand in data centers and Room ACs. However, profitability was significantly impacted, with Profit Before Tax (PBT) falling 24% to ₹126 Cr compared to ₹165 Cr in Q1 FY26. EBITDA margins contracted from 6.7% to 5.2% due to rising input costs and the depreciation of the Indian Rupee. While the Electro-Mechanical segment saw strong order bookings, the MedTech business continues to face regulatory headwinds.
Confidence: HIGH
What changedBlue Star has reported a significant divergence between top-line growth and bottom-line performance, with margins hitting a multi-quarter low despite robust sales.
Why it mattersThe margin compression in the core Room AC business, despite revenue growth, suggests intense competition or cost-push inflation that the company is struggling to pass on, which is critical for a stock trading at a high P/E of 59.5.
Revenue (Q1 FY27): ₹3,378 CrPBT (before exceptional): ₹126 CrEBITDA Margin: 5.2%EPS (Q1 FY27): ₹4.99Revenue vs TTM Revenue: 27.86%
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the 24% decline in PBT and the sharp contraction in operating margins.
📈 Long termLong-term growth depends on the successful scaling of the US/Europe export business and capturing the data center cooling market, though margin stability remains a key structural concern.
⚠ Risk flags
- Input cost inflation
- Currency depreciation (INR)
- Regulatory uncertainty in MedTech
- Pricing pressure from BEE rating changes
Key Highlights
Revenue for Q1 FY27 increased by 13.3% YoY to ₹3,378 Cr, representing ~28% of TTM revenue.
Profit Before Tax (before exceptional items) declined by 24% to ₹126 Cr from ₹165 Cr in the previous year.
EBITDA margins contracted by 150 basis points, falling to 5.2% from 6.7% in Q1 FY26.
Earnings Per Share (EPS) for the quarter dropped to ₹4.99 from ₹5.88 in Q1 FY26.
MedTech business experienced a slowdown due to continued lack of clarity in the regulatory policy framework.
👀 What to Watch
Investors should monitor the company's ability to pass on rising input costs in the Unitary Products segment and watch for the impact of the BEE energy efficiency rating change scheduled for December 2025 on inventory liquidation.
13.3% Revenue Growth in Q1FY27; Net Profit Drops 15% Amid Sharp Margin Contraction
Blue Star reported a 13.3% YoY revenue growth to ₹3,377.92 cr for Q1FY27, but net profit declined by 15.1% to ₹102.53 cr. The Unitary Products (RAC) segment saw margins collapse from 5.8% to 2.9% due to inventory liquidation and high commodity costs. A bright spot is the carried-forward order book, which grew 13.5% YoY to ₹7,764.38 cr, driven by strong demand from data centers. The company also significantly improved its net cash position to ₹900.25 cr through efficient working capital management.
Confidence: HIGH
What changedBlue Star experienced a significant margin squeeze in its consumer cooling business despite healthy top-line growth, primarily due to commodity price hikes and a shorter-than-expected summer season.
Why it mattersThe results highlight the high sensitivity of the Room AC business to seasonal weather and input costs, though the growing data center cooling segment provides a structural hedge for the long term.
Revenue (Q1FY27): ₹3,377.92 crNet Profit (Q1FY27): ₹102.53 crOrder Book vs TTM Revenue: 64.04%EBITDA Margin: 5.2%Net Cash Position: ₹900.25 crEMP Segment Order Inflow: ₹2,434.78 cr
📅 Short termThe stock may face pressure in the short term as the market reacts to the 150 bps drop in EBITDA margins and the 15% decline in bottom-line profit.
📈 Long termStructural growth remains intact with a target of $100 million in export revenue from FY28 and leadership in the expanding data center cooling market.
⚠ Risk flags
- Commodity price volatility
- Rupee depreciation
- Inventory liquidation pressure before BEE rating change
- Geopolitical uncertainty in West Asia affecting international business
Key Highlights
Revenue from operations grew 13.3% YoY to ₹3,377.92 cr in Q1FY27.
Net profit declined 15.1% to ₹102.53 cr compared to ₹120.82 cr in Q1FY26.
Unitary Products segment margins dropped to 2.9% from 5.8% in the previous year.
Total carried-forward order book increased to ₹7,764.38 cr, representing ~64% of TTM revenue.
Net cash position improved significantly to ₹900.25 cr from ₹370.92 cr YoY.
👀 What to Watch
Investors should monitor the recovery of Unitary Product margins in upcoming quarters as the company attempts to pass on cost escalations. Key triggers include the execution of the ₹5,483.73 cr EMP order book and the impact of the BEE energy rating change scheduled for December 2026.
Blue Star Q1FY27: Revenue Grows 13% to ₹3,378 Cr, but EBITDA Falls 12.5% on Margin Pressure
Blue Star reported a 13.3% YoY revenue growth to ₹3,378 Cr for Q1FY27, supported by strong demand in Room ACs and data center cooling orders. However, profitability was significantly impacted, with EBITDA declining 12.5% to ₹175 Cr and Profit Before Tax (PBT) falling 24% to ₹126 Cr. Margin compression was primarily driven by rising input costs and the depreciation of the Indian Rupee, while the MedTech segment continued to struggle due to regulatory policy uncertainties.
Confidence: HIGH
What changedBlue Star transitioned into FY27 with strong top-line momentum but faced a sharp contraction in operating margins (down 150 bps) and net profitability compared to the previous year's first quarter.
Why it mattersThe results highlight that despite high demand for cooling products, external cost pressures and currency volatility are currently outweighing volume growth, impacting the bottom line during a seasonally strong quarter.
Revenue (Q1FY27): ₹3,378 CrEBITDA (Q1FY27): ₹175 CrEBITDA Margin: 5.2%PBT (before exceptional): ₹126 CrQ1 Revenue vs TTM Revenue: ~27.9%
📅 Short termThe stock may face pressure in the short term as the market reacts to the double-digit decline in EBITDA and PBT despite healthy revenue growth.
📈 Long termStructural growth drivers like data center cooling and international expansion into the US and Europe remain intact, but margin recovery is essential for long-term value creation.
⚠ Risk flags
- Input cost inflation
- Indian Rupee depreciation
- Regulatory uncertainty in MedTech solutions
- Pricing pressure from BEE rating changes
Key Highlights
Revenue increased to ₹3,378 Cr in Q1FY27 from ₹2,982 Cr in Q1FY26, a growth of 13.3%.
EBITDA margin contracted to 5.2% from 6.7% in the same quarter last year.
Profit Before Tax (before exceptional items) dropped 24% YoY to ₹126 Cr.
Earnings Per Share (EPS) for the quarter declined to ₹4.99 from ₹5.88 in Q1FY26.
MedTech business continues to face headwinds with a reported 20.1% de-growth in the preceding period due to policy delays.
👀 What to Watch
Investors should monitor the company's ability to pass on rising input costs and the impact of the upcoming BEE energy rating changes in December 2025 on inventory pricing. Watch for any regulatory breakthroughs in the MedTech segment and the execution of data center cooling orders which are currently driving the order book.
Blue Star Q1FY27 Revenue up 13.3% to ₹3,377.92 Cr; Net Profit drops 15.2% on margin pressure
Blue Star reported a 13.3% YoY revenue growth to ₹3,377.92 crore for Q1FY27, but profitability was significantly impacted by rising input costs and a short summer season. Net profit declined 15.2% to ₹102.51 crore as EBITDA margins contracted from 6.7% to 5.2%. While the Unitary Products segment saw a sharp margin drop to 2.9% due to inventory liquidation and cost escalations, the order book remains healthy at ₹7,764.38 crore, supported by strong demand from data centers.
Confidence: HIGH
What changedRevenue grew but margins and profits declined due to commodity price hikes and a shorter-than-expected summer season impacting primary sales.
Why it mattersHigh input costs and pricing pressure in the consumer segment are currently offsetting volume gains, testing the company's pricing power and operational efficiency in a high-valuation environment (P/E of 64).
Q1 Revenue: ₹3,377.92 crNet Profit: ₹102.51 crEBITDA Margin: 5.2%Order Book: ₹7,764.38 crOrder Book vs TTM Revenue: 64.0%
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the margin contraction and profit decline, which missed historical performance levels.
📈 Long termStructural growth in data center cooling and commercial refrigeration remains a positive long-term driver, though margin volatility in the Room AC segment remains a key risk.
⚠ Risk flags
- Commodity price volatility
- Inventory pile-up in trade channels
- Geopolitical tensions affecting supply chains
Key Highlights
Consolidated Revenue grew 13.3% YoY to ₹3,377.92 crore in Q1FY27.
EBITDA margins contracted by 150 bps to 5.2% from 6.7% in Q1FY26.
Unitary Products segment result fell 43.2% to ₹49.69 crore despite 12.7% revenue growth.
Carried-forward order book increased 13.5% YoY to ₹7,764.38 crore as of June 30, 2026.
Net cash position improved to ₹900.25 crore from ₹370.92 crore in the previous year.
👀 What to Watch
Monitor the company's ability to pass on input cost increases during the upcoming festive season and the pace of inventory liquidation in the Room AC segment. Watch for the impact of the West Asia crisis on project execution and order finalization in the EMP segment.
Blue Star Q1 FY27 Results: Rs 9.17 Cr Exceptional Gain and New Independent Director Appointed
Blue Star Limited approved its Q1 FY27 financial results, featuring a standalone exceptional gain of Rs 9.17 Cr from a property sale. The company reported that five of its subsidiaries contributed Rs 235.17 Cr in revenue and Rs 10.08 Cr in PAT for the quarter. Additionally, the board appointed Mr. Nikhilesh Panchal, a senior partner at Khaitan & Co with 35 years of legal experience, as an Independent Director for a five-year term starting August 14, 2026. While the full consolidated P&L was not detailed in the summary, the subsidiary performance indicates steady international operations.
Confidence: HIGH
What changedThe company has reported its first-quarter results for FY27 and strengthened its board by appointing a legal and M&A expert as an Independent Director.
Why it mattersThe exceptional gain provides a minor one-time boost to the bottom line, while the new board appointment brings significant expertise in corporate law and foreign collaborations, supporting Blue Star's aggressive expansion into US and European markets.
Exceptional Income (Property Sale): Rs 9.17 CrSubsidiary Revenue (Q1): Rs 235.17 CrSubsidiary PAT (Q1): Rs 10.08 CrJV Net Loss (Q1): Rs 0.20 CrDirector Term: 5 years
📅 Short termThe stock may see neutral to slightly positive movement based on the exceptional gain, though the focus will remain on core operating margins in the air-conditioning segment.
📈 Long termThe appointment of a legal expert to the board is a structural positive for the company's international expansion and technology transfer goals.
⚠ Risk flags
- Pricing pressure due to BEE rating changes
- Inventory liquidation risks
- MedTech segment de-growth
Key Highlights
Recognized an exceptional income of Rs 9.17 Cr from the sale of property in the standalone results for Q1 FY27.
Five subsidiaries reported a combined revenue of Rs 235.17 Cr for the quarter ended June 30, 2026.
Consolidated net profit from these five subsidiaries stood at Rs 10.08 Cr for the same period.
Appointment of Mr. Nikhilesh Panchal as an Independent Director for a 5-year term effective August 14, 2026.
Recorded a share of net loss from joint ventures amounting to Rs 0.20 Cr for the quarter.
👀 What to Watch
Investors should review the full Q1 FY27 financial statement to assess if the 8.4% margins in the UP segment are being maintained despite the BEE energy efficiency rating changes and inventory liquidation pressures mentioned in previous filings.
Blue Star Q1 FY27: Board Approves Results, ₹9.17 Cr Exceptional Gain, and New Director Appointment
Blue Star Limited has approved its unaudited financial results for Q1 FY27, reporting an exceptional income of ₹9.17 crore from the sale of property. The consolidated performance includes a ₹235.17 crore revenue contribution and ₹10.08 crore net profit from five reviewed subsidiaries. The board also appointed Mr. Nikhilesh Panchal, a legal expert with 35+ years of experience, as an Independent Director for a five-year term starting August 14, 2026. These results follow a TTM revenue of ₹12,124 crore and a steady promoter holding of 36.5%.
Confidence: HIGH
What changedBlue Star has approved its first-quarter financials for the new fiscal year and added legal expertise to its board of directors.
Why it mattersThe results provide the first look at performance in the crucial summer quarter; the appointment of a legal veteran as Director supports governance as the company scales its US and Europe export businesses.
Exceptional Income (Property Sale): ₹9.17 crReviewed Subsidiary Revenue: ₹235.17 crReviewed Subsidiary PAT: ₹10.08 crExceptional Gain vs TTM PAT: 1.98%Director Appointment Term: 5 years
📅 Short termThe stock may see neutral to slightly positive movement based on the exceptional gain, though the core operational performance in the summer quarter will be the primary driver.
📈 Long termThe company remains focused on its 20-25% growth target and increasing its 14% market share in Room ACs through deeper Tier 2/3 penetration.
⚠ Risk flags
- Anticipated pricing pressure in Q3 FY26/27 due to BEE rating changes
- MedTech segment de-growth of 20.1%
Key Highlights
Recognized ₹9.17 crore as exceptional income from the sale of property during the quarter ended June 30, 2026.
Five subsidiaries reviewed by external auditors contributed ₹235.17 crore to the consolidated revenue for Q1 FY27.
Net profit from the aforementioned five subsidiaries stood at ₹10.08 crore for the quarter.
Appointed Mr. Nikhilesh Panchal as an Independent Director for a 5-year term, subject to shareholder approval via postal ballot.
The Group's share of net loss in joint ventures was recorded at ₹0.20 crore for the quarter.
👀 What to Watch
Investors should review the full consolidated P&L for year-on-year growth in the Room AC segment, particularly as the company approaches the December BEE rating change which may impact pricing.
Blue Star Wins Arbitration; Rs 461.74 Cr Claim by W.J. Towell & Co Dismissed
Blue Star Limited has received a favorable award from the International Chamber of Commerce (ICC) dismissing all claims filed by W.J. Towell & Co LLC (WJT). The revised claim amount was OMR 21,180,748 (approx. Rs 461.74 crore) plus 7% interest, which represented nearly 100% of Blue Star's TTM Net Profit of Rs 462 crore. The arbitrator has dismissed the entire claim, though the final award regarding interest and legal costs is still reserved for a future date. This outcome removes a significant contingent liability that had been pending since early 2024.
Confidence: HIGH
What changedA major international arbitration proceeding against Blue Star has concluded with a total dismissal of all claims made by the counterparty.
Why it mattersThe claim amount was highly material, roughly equal to the company's entire annual profit (TTM PAT Rs 462 cr). Its dismissal prevents a potential massive one-time hit to the bottom line and protects the company's net worth.
Dismissed Claim Amount: Rs 461.74 crClaim vs TTM PAT: 99.94%Claim vs Net Worth: 15.09%Interest Rate Claimed: 7%
📅 Short termThe stock is likely to react positively as the market prices out the risk of a significant legal payout.
📈 Long termThe resolution protects the company's capital for its stated 20-25% growth strategy and expansion into US/Europe markets.
⚠ Risk flags
- Potential for counterparty to challenge the award in local courts
Key Highlights
Arbitrator dismissed the total revised claim of OMR 2,11,80,748 (approx. Rs 461.74 crore).
The original claim filed in April 2024 was OMR 1,03,18,000 (approx. Rs 223.60 crore).
The dispute related to a Shareholders’ Agreement dated October 1, 2015, for managing Blue Star Oman Electro Mechanical Company.
The favorable award was received by the company on July 23, 2026.
The claim amount of Rs 461.74 crore is equivalent to approximately 15.1% of the company's Net Worth (Rs 3,060 crore).
👀 What to Watch
Investors should note the removal of this significant legal overhang; the next step is to wait for the final award regarding the recovery of legal costs and interest.
Blue Star Proposes ₹8.5 Final Dividend; 78th AGM Scheduled for August 6, 2026
Blue Star Limited has issued a notice for its 78th Annual General Meeting (AGM) to be held on August 6, 2026. The primary agenda includes the declaration of a final dividend of ₹8.5 per equity share (face value ₹2) for FY26. The company has fixed July 17, 2026, as the record date for dividend eligibility. With a TTM revenue of ₹12,124 Cr and a PAT of ₹462 Cr, the proposed dividend represents a payout based on a stable financial performance in the previous fiscal year.
Confidence: HIGH
What changedThe company has formalized the date for its 78th AGM and confirmed the specific dividend amount and record date for shareholders.
Why it mattersThis is a routine but significant event for shareholders to receive their annual return on investment and vote on key items like director re-appointments and auditor remuneration.
Final Dividend: ₹8.5 per shareRecord Date: July 17, 2026Dividend Yield (approx): 0.50%TTM Revenue: ₹12,124 CrTTM PAT: ₹462 Cr
📅 Short termThe stock may see minor price adjustments around the ex-dividend date (typically one day before the record date) as the market factors in the ₹8.5 payout.
📈 Long termLimited; this is a routine administrative filing. Long-term focus remains on the company's expansion into US/Europe markets and market share gains in the Room AC segment.
Key Highlights
Final dividend of ₹8.5 per equity share (face value ₹2) proposed for FY26
Record date for dividend eligibility set for July 17, 2026
78th AGM scheduled for August 6, 2026, at 3:30 p.m. IST via Video Conferencing
Remote e-voting period starts August 1, 2026, and ends August 5, 2026
TTM Revenue of ₹12,124 Cr with an Operating Profit Margin of 7.6%
👀 What to Watch
Investors should note the record date of July 17, 2026, to be eligible for the ₹8.5 dividend. The upcoming Q1 FY27 results in August 2026 will be the next major catalyst to monitor for growth execution.
₹8.5 Dividend Proposed; Blue Star Schedules 78th AGM for August 6, 2026
Blue Star Limited has issued the notice for its 78th Annual General Meeting (AGM) scheduled for August 6, 2026. The primary agenda includes the declaration of a final dividend of ₹8.5 per equity share (425% of face value) for FY26. The company has fixed July 17, 2026, as the record date for determining dividend eligibility. This follows a financial year where the company reported TTM revenue of ₹12,124 Cr and a PAT of ₹462 Cr.
Confidence: HIGH
What changedThe company has formalized the date for its 78th AGM and confirmed the specific dividend amount and record date for FY26.
Why it mattersThis is a routine but significant event for shareholders as it confirms the timing of cash returns (dividend) and provides the full Integrated Annual Report for detailed operational review.
Final Dividend: ₹8.5 per shareDividend Yield (at current price): 0.50%Record Date: July 17, 2026TTM Revenue: ₹12,124 CrTTM PAT: ₹462 Cr
📅 Short termThe stock may see minor price adjustments around the July 17 record date as it goes ex-dividend.
📈 Long termLimited structural significance from this filing; long-term focus remains on the company's 20-25% growth target and market share expansion in the Room AC segment.
Key Highlights
Final dividend of ₹8.5 per equity share of ₹2 face value proposed for FY26
Record date for dividend eligibility set for July 17, 2026
78th AGM to be held on August 6, 2026, via Video Conferencing
Remote e-voting period scheduled from August 1 to August 5, 2026
TTM Revenue of ₹12,124 Cr and PAT of ₹462 Cr provide the financial backdrop for the payout
👀 What to Watch
Investors should note the record date of July 17, 2026, to be eligible for the ₹8.5 dividend. Review the Integrated Annual Report for updates on the US/Europe export strategy and MedTech segment recovery.
Blue Star Announces ₹8.5 Dividend for FY26; Record Date Set for July 17, 2026
Blue Star Limited has recommended a final dividend of ₹8.5 per equity share (face value ₹2) for the financial year ended March 31, 2026. The company has established July 17, 2026, as the record date to determine eligibility for the payout, which is subject to shareholder approval at the AGM on August 6, 2026. Tax Deduction at Source (TDS) will apply at 10% for resident individuals with a valid PAN if the dividend exceeds ₹10,000, and 20% for those without. Non-resident shareholders may claim treaty benefits by submitting required documentation by July 10, 2026.
Key Highlights
Recommended final dividend of ₹8.5 per equity share of face value ₹2 for FY 2025-26.
Record date for determining dividend entitlement is fixed as Friday, July 17, 2026.
Dividend payment is scheduled to occur after the Annual General Meeting on August 6, 2026.
Standard TDS rate of 10% for resident individuals with PAN; 20% for non-residents or those without PAN.
Deadline for submitting tax-related exemption documents is Friday, July 10, 2026.
👀 What to Watch
Investors should ensure their PAN and bank account details are updated with their Depository Participant and submit tax exemption forms by July 10 to avoid higher TDS. To be eligible for the ₹8.5 dividend, shares must be held in the portfolio as of the record date, July 17, 2026.
Blue Star to Acquire Remaining 51% Stake in Blue Star Qatar for up to ₹50 Lakh
Blue Star Limited has approved the acquisition of the remaining 51% shareholding in its subsidiary, Blue Star Qatar W.L.L. (BSQ), from its local partner Al Malki Trading & Contracting Co. Although Blue Star already held 95% economic interest and management control, this move will make BSQ a wholly-owned subsidiary. The acquisition follows regulatory changes in Qatar that now permit 100% foreign ownership. The total consideration is capped at ₹50 lakh, and the transaction is expected to be completed within eight months.
Key Highlights
Acquisition of 51% stake in Blue Star Qatar W.L.L. to convert it into a wholly-owned subsidiary
Total cash consideration for the 51% stake is capped at ₹50 lakh
Blue Star Qatar reported a turnover of QAR 25 million for FY26, down from QAR 53 million in FY24
The move simplifies the corporate structure following Qatar's regulatory shift to allow 100% foreign ownership
Transaction is subject to approvals from the RBI and Qatari authorities, with an 8-month completion target
👀 What to Watch
This is a minor structural simplification with negligible financial impact on Blue Star's consolidated performance. Investors should remain focused on the company's primary growth drivers in the Indian cooling and MEP markets.
Blue Star Q4 FY26 Revenue Hits Record ₹4,072 Cr; Recommends ₹8.5 Dividend
Blue Star reported its highest-ever quarterly revenue of ₹4,072 crore in Q4 FY26, marking a 1.3% YoY growth despite a challenging year. While annual net profit for FY26 declined by 4.3% to ₹527.3 crore due to supply chain headwinds and a weak initial summer, the company's order book remains robust at ₹6,923 crore. The Board has recommended a dividend of ₹8.5 per share. Management expressed cautious optimism for FY27, citing a strong start to the summer season in April 2026.
Key Highlights
Q4 FY26 consolidated revenue grew 1.3% YoY to ₹4,072 crore, while EBITDA margins improved to 8%.
Full-year FY26 revenue increased 3.6% to ₹12,402 crore, though net profit fell to ₹527.3 crore.
The carried forward order book grew by 10.5% YoY to reach ₹6,923 crore as of March 31, 2026.
Unitary Products (Segment 2) margins improved to 10.4% in Q4 FY26 from 8.4% in the previous year.
Board recommended a dividend of ₹8.5 per share for the financial year ended March 31, 2026.
👀 What to Watch
Investors should focus on the recovery in the room air conditioner segment and the strong order book in electromechanical projects. While Q4 showed margin improvement, watch for the impact of rising input costs and geopolitical supply chain disruptions in FY27.
Blue Star Q4 Net Profit Rises 17% to ₹227 Cr; FY26 Dividend Recommended at ₹8.5 Per Share
Blue Star reported a modest 1.3% revenue growth in Q4FY26 to ₹4072.06 cr, though net profit surged 17.1% to ₹227.18 cr driven by improved EBITDA margins of 8.0%. For the full year FY26, the company faced headwinds with net profit declining 10.8% to ₹527.33 cr, primarily due to a challenging environment and exceptional items related to labor codes. The order book remains healthy at ₹6923 cr, up 10.5% YoY, providing revenue visibility for the upcoming year. The Board recommended a dividend of ₹8.5 per share, slightly lower than the previous year's ₹9.
Key Highlights
Q4FY26 Net Profit grew 17.1% YoY to ₹227.18 cr, while Revenue saw a marginal 1.3% increase to ₹4072.06 cr.
Full-year FY26 Net Profit declined by 10.8% to ₹527.33 cr despite a 3.6% growth in total revenue to ₹12401.99 cr.
Carried-forward order book grew 10.5% to ₹6923 cr as of March 31, 2026, with strong Q4 order inflows in the Projects segment.
Unitary Products (AC segment) margins improved significantly to 10.4% in Q4 from 8.4% YoY due to cost rationalization.
Recommended dividend of ₹8.5 per share for FY26, representing a slight decrease from ₹9.0 in FY25.
👀 What to Watch
Investors should monitor the sustainability of the margin expansion in the Unitary Products segment and the execution of the ₹6,923 cr order book. While full-year profits were down, the strong Q4 performance and pickup in summer demand in April 2026 suggest a potential recovery in FY27.
Blue Star Q4 FY26 EBITDA Grows 16.8% to ₹326 Cr; Revenue Hits ₹4,072 Cr
Blue Star reported a steady Q4 FY26 with revenue growing marginally to ₹4,072 crore, while EBITDA saw a significant 16.8% increase to ₹326 crore. The Unitary Products segment (Room ACs) showed margin improvement to 10.4% despite stagnant growth in deep freezers. However, full-year EPS declined to ₹25.65 from ₹28.76, impacted by a ₹38 crore exceptional one-time charge related to new labor codes. The company maintains a healthy balance sheet with a net cash position of ₹175 crore and a low debt-equity ratio of 0.18.
Key Highlights
Q4 FY26 EBITDA increased to ₹326 crore from ₹279 crore in the previous year, with margins improving to 8.0%.
Unitary Products EBIT margins improved significantly to 10.4% in Q4 FY26 from 8.4% YoY.
Electro-Mechanical Projects (EMP) order bookings grew by 35% driven by demand from Data Centers and Factories.
Full-year FY26 revenue reached ₹12,402 crore, though EPS fell to ₹25.65 due to a ₹38 crore exceptional gratuity impact.
Net cash position decreased to ₹175 crore from ₹640 crore YoY, while the debt-equity ratio remains low at 0.18.
👀 What to Watch
Investors should monitor the margin recovery in the EMP segment and the scalability of the US/Europe expansion. While Q4 was strong, the full-year earnings dip and lower net cash suggest a need for a cautious outlook on immediate valuation upside.
Blue Star Q4 Net Profit Rises 17% to Rs 227 Cr; FY26 Dividend Declared at Rs 8.5/Share
Blue Star reported a record quarterly revenue of Rs 4072.06 crore in Q4FY26, up 1.3% YoY, driven by a late surge in Room Air Conditioner demand. While Q4 net profit grew 17% to Rs 227.18 crore, the full-year FY26 net profit saw a 4.3% decline to Rs 527.33 crore due to challenging conditions earlier in the year. The company's order book remains robust at Rs 6923 crore, representing a 10.5% YoY growth. Management has recommended a dividend of Rs 8.5 per share and remains cautiously optimistic for FY27 as summer demand picked up in April 2026.
Key Highlights
Q4FY26 EBITDA margins improved to 8.0% from 7.0% YoY, driven by cost rationalization and prudent pricing.
Carried-forward order book grew 10.5% YoY to reach Rs 6923 crore as of March 31, 2026.
Segment II (Unitary Products) margins rose to 10.4% in Q4FY26 compared to 8.4% in the previous year.
Full-year FY26 revenue grew 3.6% to Rs 12401.99 crore, though PBT before exceptional items fell 3.9%.
Board recommended a dividend of Rs 8.5 per share for FY26, down from Rs 9 per share in FY25.
👀 What to Watch
Investors should focus on the strong Q4 margin recovery and the 10.5% growth in the order book as indicators of future performance. The reported pickup in secondary sales in April 2026 suggests a potentially strong start to FY27, making the next quarter's volume growth a key metric to watch.
Blue Star Q4 FY26 Revenue Grows 12% to ₹2,790 Cr; EBITDA Margins Expand to 8%
Blue Star reported a steady Q4 FY26 with revenue growing 12% YoY to ₹2,790 crore and EBITDA margins improving to 8% from 7% in the previous year. While the full-year revenue grew modestly by 3.6% to ₹12,402 crore, the company faced a one-time exceptional hit of ₹38 crore due to new labor code provisions affecting full-year EPS. Segment 1 (EMP) saw strong order booking growth of 35% in Q4, while Segment 2 (Unitary Products) margins improved significantly to 10.4%. The company maintains a healthy balance sheet with a low debt-equity ratio of 0.18.
Key Highlights
Q4 FY26 Revenue increased 12% YoY to ₹2,790 crore, with EBITDA rising 16.8% to ₹326 crore.
Unitary Products (Room ACs) segment EBIT margins improved to 10.4% in Q4 from 8.4% YoY.
Electro-Mechanical Projects (EMP) saw a robust 35% growth in order bookings during the quarter.
Full-year FY26 results were impacted by a ₹38 crore exceptional charge for gratuity and leave encashment.
Net cash position decreased to ₹175 crore from ₹640 crore, while Debt-Equity ratio remains low at 0.18.
👀 What to Watch
Investors should focus on the strong margin recovery in the Unitary Products segment and the robust order pipeline in EMP. The stock remains a solid play on India's cooling and infrastructure growth, though full-year growth was slightly muted due to one-off costs.
Blue Star Recommends ₹8.5 Dividend; Approves Audited FY26 Financial Results
Blue Star's Board has recommended a final dividend of ₹8.5 per equity share (425% of face value) for the financial year ended March 31, 2026. The company approved its audited financial results for FY26, which received an unmodified opinion from statutory auditors Deloitte Haskins & Sells LLP. The record date for the dividend is set for July 17, 2026, with the payout expected after the Annual General Meeting on August 6, 2026. This announcement signals a steady return to shareholders alongside the completion of the fiscal year.
Key Highlights
Recommended a final dividend of ₹8.5 per equity share of ₹2 face value for FY26.
Fixed July 17, 2026, as the Record Date for determining dividend eligibility.
Approved audited standalone and consolidated financial results for the year ended March 31, 2026.
Statutory auditors issued an unmodified audit report, confirming financial transparency.
The 78th Annual General Meeting (AGM) is scheduled for August 6, 2026.
👀 What to Watch
Investors seeking dividend income should ensure they hold shares by the record date of July 17, 2026. The clean audit report and substantial dividend payout suggest stable financial health for the company.
Blue Star Recommends ₹8.5 Final Dividend and Approves FY26 Audited Results
Blue Star Limited's Board has recommended a final dividend of ₹8.5 per equity share for the financial year ended March 31, 2026. The company also approved its audited financial results for FY26, which received a clean, unmodified report from statutory auditors Deloitte Haskins & Sells LLP. The record date for dividend eligibility is fixed as July 17, 2026, with the payout scheduled after the Annual General Meeting on August 6, 2026. This announcement confirms the company's year-end financial performance and shareholder reward policy.
Key Highlights
Recommended a final dividend of ₹8.5 per equity share of ₹2 face value for FY26.
Record date for the final dividend is set for July 17, 2026.
Approved audited standalone and consolidated financial results for the year ended March 31, 2026.
Statutory auditors issued an unmodified audit report on the financial results.
The 78th Annual General Meeting (AGM) is scheduled for August 6, 2026.
👀 What to Watch
Investors seeking dividend income should ensure they hold shares before the record date of July 17, 2026. The unmodified audit report is a positive sign of financial transparency and reporting integrity.
